Progyny (PGNY)
(Delayed Data from NSDQ)
$16.46 USD
-7.98 (-32.65%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $16.56 +0.10 (0.61%) 6:10 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Price, Consensus and EPS Surprise
PGNY 16.46 -7.98(-32.65%)
Will PGNY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PGNY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PGNY
Do Options Traders Know Something About Progyny (PGNY) Stock We Don't?
Progyny (PGNY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
PGNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Progyny (PGNY) Beats Q2 Earnings Estimates
Earnings Preview: Embecta Corp. (EMBC) Q3 Earnings Expected to Decline
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth
Other News for PGNY
Progyny stock falls as JMP Securities downgrades after loss of client
Market Today: Federal Reserve's Rate Cut Sparks Volatility, Intuitive Machines Soars on NASA
Progyny discloses loss of 'significant client'
Closing Bell Movers: Steelcase down 10% on soft top-line results, guidance
Progyny discloses loss of 'significant client'